Failure Modes and Effects Analysis (FMEA)

Size: px
Start display at page:

Download "Failure Modes and Effects Analysis (FMEA)"

Transcription

1 Failure Modes and Effects Analysis (FMEA) Sasa Mutic Washington University School of Medicine St. Louis Missouri

2 Failure Modes and Effects Analysis Objectives: To motivate the use of FMEA and to provide an introduction to the application of FMEA in RT To illustrate the dependence of the results of an FMEA on the approach used and on the individuals performing the analysis FMEA is a tool 2

3 Modern RT Recent sophistication large fraction of modern treatment practices developed in the past ten years High technical complexity Multiple systems (software and hardware) non-existent guidance and regulations Limited to non High pressure Increased potential for catastrophic failures To error is human. To really foul things up requires a computer.

4 Systems Engineering The function of systems engineering is to guide the engineering of complex systems It is founded on a belief that individual components of an organization are dependent on each other It is very much about employing common sense in design of operations A set of tools for more effective management of interconnected components

5 Systems Engineering Applicable to systems with the following attributes: Complex Engineered Advanced technology High risk RT High cost Modern

6 Systems Engineering Systems Design Quality systems Human factors FMEA Systems Analysis Modeling and simulation Enterprise management Financial engineering and risk analysis Knowledge discovery Systems Control SPC Scheduling

7 Systems Engineering It is difficult for engineers to change human nature and therefore, instead of trying to persuade people not to make errors, we should accept people as we find them and try to remove opportunities for error by changing work situation. An engineers view of human error - Trevor Kletz

8 Systems Engineering in Healthcare An outline for use of Systems Engineering for improvement of national health care system We often call this arrangement a health care system even though it was never created as a system and has never performed as a system. National Academy of Engineering and Institute of Medicine, 2005

9 Failure Modes and Effects Analysis Failure Modes and Effects Analysis (FMEA) Identifies ways that a sub-process or product can fail and develops plans to prevent those failures. FMEA is especially useful with high-risk projects. The FMEA process is a dynamic,, structured approach that has the goal of linking the FAILURE MODES to an EFFECT over time for the purpose of prevention. /FMEA-&- Measurement_Systems_Analysis.ppt 9

10 Failure Modes and Effects Analysis What s s the point? Provides a structured way of prioritizing risk. Helps to focus efforts aimed at minimizing adverse outcomes. How does FMEA do that? Assembles a group of people (experts) and asks them to dream up potential risks (failure modes) and to assign a few numbers to them. Numbers are easy to sort. 10 The purpose of computing is insight, not numbers! R.W. Hamming

11 Failure Modes and Effects Analysis It can be used as a standalone tool or as a part of a broader quality system FMEA part of FDA process Applications: Equipment/product d QA/QC development Process development 11

12 Failure Modes and Effects Analysis Vocabulary Failure Mode: : How a part or process can fail to meet specifications. Cause: : A deficiency that results in a failure mode; sources of variation. Effect: : Impact on customer if the failure mode is not prevented or corrected. 12

13 Failure definition and spectrum Publicized - One side of the spectrum, usually large dosimetric errors NY Times Articles Semi-publicized RPC data Approximately 30% of participating institutions fail to deliver IMRT dose indicated in their treatment plans to within 7% or 4mm to an anthropomorphic phantom (IJROBP. 2008;71(1 Suppl):S71-5). Unpublicized/unnoted everyday occurrences Small dosimetric errors and geographic misses Suboptimal treatment plans (contouring and dose distributions) Care coordination issues Unnecessary treatment delays

14 Organizational Goals RT - Service or Manufacturing Industry? Quality Patient and employee safety Patient and employee satisfaction Efficiency 14

15 Process Itself Matters High-quality means minimizing process variation and moving the average closer to the optimum value - Med. Phys., (5): p Stable and well defined processes enable: Standardization Quantification Benchmarking Improvements Quality Control

16 FMEA Structure/Process Process Step A Process Step B Process Step C Process Step D Identify Potential Failure Mode Identify Potential Effect(s) of Failure Mode Determine Severity Identify Potential Cause(s) of Failure Mode Determine Occurance Evaluate Current Controls or Design Verification Process Determine Detectability Determine RPN Identify Actions Leading to Improvement 16

17 Failure Modes and Effects Analysis Identifying potential failure modes Must be comprehensive Must be unambiguous remove interpretation May be linked to severity Identifying potential effect(s) of failure mode Use most severe Easiest one to agree on 17

18 FMEA in Numbers Occurrence (O) describes the probability that a particular cause for the occurrence of a failure mode occurs. (1-10) 10) Severity (S) describes the severity of the effect on the final process outcome resulting from the failure mode if it is not detected or corrected. (1-10) 10) Lack of Detectability (D) describes the probability that the failure will not be detected. (1-10) 10) 18

19 RPN Score Three part system Probability of failure - O Severity of failure - S Probability that a failure would NOT be detected - D Probability of error Severity Probability no detection RPN A B C A*B*C Risk Priority Number (RPN) = Frequency * Severity * Probability 19

20 Scoring frequency of failure Qualitative Review Ranking Failure Rate Failure is unlikely 1 < 100 ppm Few failures 3 < 500 ppm Occasional failure 6 < 0.5 % Repeated failures 8 < 2.0 % Failures are inevitable 10 > 5.0 % 20

21 Six Sigma Levels of Performance Sigma Level DPMO Error as % Quality Yield Cost of Quality/Cost of Poor Quality as % of Total Operating Cost 2 308, % 69.0% Uncompetitive 3 66, % 93.3% 24-40% 4 6, % 99.4% 15-20% % 99.98% 5-15% % % World Class The Journal of Emergency Medicine, Vol. 38, No. 1, pp ,

22 Scoring Severity of Failure Severity Rank Minor to Inconvenience 1-3 Minor dosimetric error 4 Limited toxicity 5-6 Serious toxicity 7-9 Catastrophic 10 22

23 Probability that a failure will NOT be detected Probability Rank 1/10, / / / / /50 8 1/20 9 1/

24 Failure Modes and Effects Analysis NO special QA\QC QC in place for any of the processes or equipment Errors are discovered only downstream through routine processes Drastically different from all our training and beliefs Challenging to continuously remember 24

25 Failure Modes and Effects Analysis Identifying potential cause(s) of failure mode Depends on experience Often get a wide spread Evaluate current controls or design verification process Assume no QC This is difficult to do for us 25

26 Failure Modes and Effects Analysis Each failure can have multiple causes Each failure can have multiple consequences Example Isocenter misplacement Causes Laser misalignment Patient setup misinterpretation Many others.. Consequences/Severity Depend on magnitude of misplacement Use the most sever one 26

27 Failure Modes and Effects Analysis Two major challenges in completing an FMEA 1.To be confident that all possible significant failure modes have been identified. This requires that experts contributing to the FMEA have a wide range of experience 2.The description of the failure mode must be completely clear and different sources that result in the same failure must be differentiated. Different sources may result in the same failure but will have different likelyhoods of occurrence. 27 ICRP Publication Preventing Accidental Exposures from New External Beam Radiation Therapy Technologies

28 AAPM - TG100 FMEA Application of Risk Analysis Methods to Radiation Therapy Quality Management 28

29 TG100 IMRT Example STEP 1. Process Steps 1. Diagnosis, Staging, History and Physical 2. Patient entered in database, assigned db keys, etc 3. Decision to Treat with Radiation 4. Scheduling for Planning Process 5. Immobilization and Positioning 6. Each Imaging Procedure (CT, MR, PET ) 7. Transfer Images 29

30 TG100 IMRT Example STEP 1. Process Steps 8. Initial Treatment Planning Directive (from MD) 9. RTP Anatomy 10. MD Review 11. Plan Review 12. Plan Approval 13. Plan Prep 14. IMRT QA 15. Clinical Plan Prep 16. Day 1 Treatment: 17. Day n Tx: 18. Weekly Chart Check: 19. Therapy Complete 30

31 TG100 IMRT Example Single Step - Subcategories 9. RTP Anatomy : Import images into RTP system db Create case (anatomy) Import appropriate image datasets into case Dataset registration (fusion) of multiple datasets Delineate targets (MD) and normal structures for planning, optimization Complete anatomical description (objects, fusion, 3-D D review, etc) 31

32 TG100 IMRT Example STEP 2. Process Map Immobilization and positioning Transfer patient data to treatment delivery Clinical plan prep Manual data entry and plan modification Immobilization equipment fabricated MD review Specify treatment course Immobilization equipment documented, labeled, and stored Check anatomy Plan review by dosimetrist Delivery protocols Scheduling Chart filing Patient database information entered Data into electronic database RTP anatomy contouring Prescription Check that previous treatments were accounted for Check normal tissue and target goals, dose distributions Physics Check Equipment Check Data into written chart Import and fuse images MD: delineate GTV Delineate ROIs and planning structures Check dose calc method Check beams, machines, etc. DQA Chart Check Imaging and diagnosis Edit density map for artifacts PTV construction Plan approval Review of patient medical history Weekly chart checks Successful treatment Decision of protocol Decision of treatment technique Scheduling for planning process Immobilization equipment documented, labeled, and stored Immobilization for Imaging study Immobilization equipment fabricated Patient prepped (contrast, tattoos, BBs etc.) Set up data documented Specify images for target/structure delineation Specify protocol for delineating target and structures Specify registration goals Indicate motion/uncertainty management Suggest initial guidelines for treatment parameters Specify dose limits and goals Construct Blocks Compensators Bolus, Etc Dosimetrist check Plan preparation Documentation Treatment Dosimetry Physics Positioning Scheduling MD Subsequent treatments Treatment review Consultation and decision to treat Enter prescription Setup fields Setup dose calc parameters Optimization Time out Imaging (CT/PET/MR) Evaluate plan Positioning Treatment planning Documentation 32 Transfer images and other DICOM data: primary and secondary data transferred Initial treatment planning directive Initial treatment Imaging (port films, CBCT, etc) Treatment

33 TG100 IMRT Example Failure Modes Process Number of Failure Modes Patient Entered into database 3 Immobilization and positioning 7 CT Simulation 13 Other imaging studies 7 Transfer of images and other DICOM data 8 Initial treatment directive from MD 9 Define anatomy for treatment planning 31 33

34 TG100 IMRT Example Failure Modes Process Number of Failure Modes Treatment planning 53 Plan approval 11 Prepare plan for delivery 30 First session treatment 20 Subsequent treatments 23 34

35 35 Table Example

36 TG100 IMRT Example STEP 3. FMEA Three part system Probability of failure - O Severity of failure - S Probability that a failure would NOT be detected - D Probability of error Severity Probability no detection RPN A B C A*B*C Risk Priority Number (RPN) = Frequency * Severity * Probability 36

37 TG-100 OSD Scores Nine of the TG members assigned O, S, D values Average OSD and RPN values and corresponding standard deviations created Highest and lowest median RPN scores used to identify most and least critical steps 10% and 20% values in both directions used as threshold Result is High risk steps (HM10 and HM20) and Low risk steps (LM10 and LM20) Steps with severity higher than 8 are given special priority regardless of RPN value 37

38 Your OSD Scores 38 Start with TG-100 scores VERY GOOD LEARNING TOOL Start with blank process and develop your own program Involve multiple groups Administrative Dosimetry Physics Clinical (Physicians) Therapy Nursing Develop individual OSD and RPN scores and analyze the data

39 Interactive Example Incorrect Capping Step Potential failure mode Evaluate ROIs (targets and structures) Incorrect ROI volumes Cause Inadequate design/programming Potential Cause Inadequate contour capping algorithm (3D expansion) Potential Effects Wrong dose, suboptimal plan 39

40 Interactive Example Incorrect Capping Frequency O 1 to 3 3 to 7 7 and higher Severity S 1 to 3 3 to 7 7 and higher Detectability D 1 to 3 3 to 7 7 and higher 40

41 Interactive Example Incorrect Capping TG-100 Scores Probability of error Severity Probability no detection RPN Mean SD

42 TG-100 Lessons Scoring overall inconsistent with unclear trends High and low RPN values scored much more uniformly Example High RPN: Failure to notice that MLC leaves are not moving O (3.33 ± 0.87), S (8.22±1.2), D (8.22±1.56) and RPN (221.7 ± 64.8) 42

43 STEP 5/6. Process Map Marking Shows if potential failures are uniformly distributed through the process or clustered If clustered, should consider the major step as a hazard Design QM processes according to clustered areas and severity scores 43

44 44 Process Map Marking

45 Conclusions FMEA can be used as a standalone effort or as a part of a broader process improvement effort Best performed with all involved groups (content experts) Need a facilitator lead person with expertise in FMEA A broad spectrum of outcomes, from better insight and understanding to a much better product or service 45

Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT

Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT Wen Li, Andrew Vassil, Lama Mossolly, Qingyang Shang, Ping Xia Department of Radiation Oncology Why

More information

Key words: treatment planning, quality assurance, 3D treatment planning

Key words: treatment planning, quality assurance, 3D treatment planning American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning Benedick Fraass a) University of Michigan Medical

More information

Accreditation Is Coming

Accreditation Is Coming Accreditation Is Coming Accreditation Is Coming Accreditation Is Coming Yes, It Is! Currently, Accreditation is Voluntary However, Some of the Accrediting Organizations Are Lobbying the Congress to Adopt

More information

FMEA Failure Risk Scoring Schemes

FMEA Failure Risk Scoring Schemes FMEA Failure Risk Scoring Schemes 1-10 Scoring for Severity, Occurrence and Detection CATEGORY Severity 10 9 8 7 6 5 3 2 1 Hazardous, without warning Hazardous, with warning Very High High Moderate Low

More information

kv-& MV-CBCT Imaging for Daily Localization: Commissioning, QA, Clinical Use, & Limitations

kv-& MV-CBCT Imaging for Daily Localization: Commissioning, QA, Clinical Use, & Limitations kv-& MV-CBCT Imaging for Daily Localization: Commissioning, QA, Clinical Use, & Limitations Moyed Miften, PhD Dept of Radiation Oncology University of Colorado Denver Questions Disease Stage (local, regional,

More information

THE DOSIMETRIC EFFECTS OF

THE DOSIMETRIC EFFECTS OF THE DOSIMETRIC EFFECTS OF OPTIMIZATION TECHNIQUES IN IMRT/IGRT PLANNING 1 Multiple PTV Head and Neck Treatment Planning, Contouring, Data, Tips, Optimization Techniques, and algorithms AAMD 2013, San Antonio,

More information

The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2

The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2 The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2 Taxonomy Data Category Number Description Data Fields and Menu Choices 1. Impact 1.1 Incident

More information

Preface to Practice Standards

Preface to Practice Standards 0 0 0 0 Preface to Practice Standards A profession s practice standards serve as a guide for appropriate practice. The practice standards define the practice and establish general criteria to determine

More information

Quality Assurance of Radiotherapy Equipment

Quality Assurance of Radiotherapy Equipment Clinical Implementation of Technology & Quality Assurance in Radiation Oncology For the course: Survey of Clinical Radiation Oncology 1 Quality Assurance of Radiotherapy Equipment Outline: A. Criteria

More information

1. Provide clinical training in radiation oncology physics within a structured clinical environment.

1. Provide clinical training in radiation oncology physics within a structured clinical environment. Medical Physics Residency Program Overview Our Physics Residency Training is a 2 year program typically beginning July 1 each year. The first year resident will work closely with medical physicists responsible

More information

NIA RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning

NIA RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning NIA RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed Date: November,

More information

Radiation Therapy. 1. Introduction. 2. Documentation of Compliance. 3. Didactic Competency Requirements. 4. Clinical Competency Requirements

Radiation Therapy. 1. Introduction. 2. Documentation of Compliance. 3. Didactic Competency Requirements. 4. Clinical Competency Requirements PRIMARY CERTIFICATION DIDACTIC AND CLINICAL COMPETENCY REQUIREMENTS EFFECTIVE JANUARY 2014 Radiation Therapy 1. Introduction Candidates for certification and registration are required to meet the Professional

More information

Upon completion of this activity, the participant should be able to:

Upon completion of this activity, the participant should be able to: The Utility of Root Cause Analysis and Failure Mode and Effects Analysis in the Hospital Setting Learning objectives: Upon completion of this activity, the participant should be able to: 1. Discuss the

More information

HDR Brachytherapy 1: Overview of QA. Disclosures: Learning Objectives 7/23/2014

HDR Brachytherapy 1: Overview of QA. Disclosures: Learning Objectives 7/23/2014 HDR Brachytherapy 1: Overview of QA Bruce Libby Department of Radiation Oncology University of Virginia Health System Disclosures: Nondisclosure agreement with Varian Brachytherapy Shareholder- Varian,

More information

FMEA and FTA Analysis

FMEA and FTA Analysis FMEA and FTA Analysis Why it is Coming to Your Hospital and Your Laboratory Tina A. Krenc Director, R&D Phase Systems Abbott Laboratories 1 Agenda Background on requirements for risk management Tools to

More information

NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM

NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM Purpose: To provide licensees and registrants with a

More information

ELECTRONIC MEDICAL RECORDS (EMR) STREAMLINE CH I PROCESS. Ping Xia, Ph.D. Head of Medical Physics Department of Radiation Oncology Cleveland Clinic

ELECTRONIC MEDICAL RECORDS (EMR) STREAMLINE CH I PROCESS. Ping Xia, Ph.D. Head of Medical Physics Department of Radiation Oncology Cleveland Clinic ELECTRONIC MEDICAL RECORDS (EMR) STREAMLINE CH I PROCESS Ping Xia, Ph.D. Head of Medical Physics Department of Radiation Oncology Cleveland Clinic Disclosure I have received research grants from Siemens

More information

Quality Assurance in Stereotactic. Radiotherapy

Quality Assurance in Stereotactic. Radiotherapy Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy David Shepard, Ph.D. Swedish Cancer Institute Seattle, WA Timothy D. Solberg, Ph.D. University of Texas Southwestern

More information

IBA Proton Therapy. Biomed days 2015. Vincent Bossier. System Architect [email protected]. Protect, Enhance and Save Lives

IBA Proton Therapy. Biomed days 2015. Vincent Bossier. System Architect Vincent.bossier@iba-group.com. Protect, Enhance and Save Lives Vincent Bossier System Architect [email protected] IBA Proton Therapy Biomed days 2015 Protect, Enhance and Save Lives 1 Agenda AN INTRODUCTION TO IBA WHY PROTON THERAPY CLINICAL WORKFLOW TREATMENT

More information

M D Anderson Cancer Center Orlando TomoTherapy s Implementation of Image-guided Adaptive Radiation Therapy

M D Anderson Cancer Center Orlando TomoTherapy s Implementation of Image-guided Adaptive Radiation Therapy M D Anderson Cancer Center Orlando TomoTherapy s Implementation of Image-guided Adaptive Radiation Therapy Katja Langen, PhD Research supported by TomoTherapy Inc. Today s Lecture Introduction to helical

More information

Process Failure Modes and Effects Analysis PFMEA for Suppliers

Process Failure Modes and Effects Analysis PFMEA for Suppliers Process Failure Modes and Effects Analysis PFMEA for Suppliers Copyright 2003-2007 Raytheon Company. All rights reserved. R6σ is a Raytheon trademark registered in the United States and Europe. Raytheon

More information

Manual VIRTUAL RADIATION ONCOLOGY CLINIC (VROC) (1.1) Radiation Oncology Training. Director User Manual (1.1)

Manual VIRTUAL RADIATION ONCOLOGY CLINIC (VROC) (1.1) Radiation Oncology Training. Director User Manual (1.1) Manual 1 VIRTUAL RADIATION ONCOLOGY CLINIC (VROC) (1.1) Radiation Oncology Training Director User Manual (1.1) Virtual Radiation Oncology Clinic Resident User manual Chapter 1 Creating the Virtual Patient

More information

Our Department: structure and organization

Our Department: structure and organization EORTC meeting for Radiation Therapy Technologists: RTT s role in the modernization of radiotherapy 10th October 2014, Villejuif (Grand Paris), France Elekta Stereotactic Body Frame: transmission modelled

More information

RADIATION THERAPY. Dosimetry Pioneers since 1922 NEW

RADIATION THERAPY. Dosimetry Pioneers since 1922 NEW RADIATION THERAPY Dosimetry Pioneers since 1922 NEW New Product Releases 2015 One phantom multiple options 4D Patient and Machine QA Modular Phantom for Stay flexible. Go modular. } Revolutionary new modular

More information

Design Failure Modes and Effects Analysis DFMEA with Suppliers

Design Failure Modes and Effects Analysis DFMEA with Suppliers Design Failure Modes and Effects Analysis DFMEA with Suppliers Copyright 2003-2007 Raytheon Company. All rights reserved. R6σ is a Raytheon trademark registered in the United States and Europe. Raytheon

More information

Comprehensive Evaluation of Radiation Oncology Information Systems (ROIS)

Comprehensive Evaluation of Radiation Oncology Information Systems (ROIS) Comprehensive Evaluation of Radiation Oncology Information Systems (ROIS) Luis Fong, Ph.D. Michael Herman, Ph.D. Several Layers of Complexity Consultation Patient Information Prescription Main Hospital

More information

Quality Assurance of accelerators; the technologists responsibility

Quality Assurance of accelerators; the technologists responsibility Quality Assurance of accelerators; the technologists responsibility Christa Timmermans Radiation Technologist, Erasmus MC- Daniel den Hoed, Rotterdam, The Netherlands EORTC-ROG RT technologists Section

More information

7/21/2014. Quality Metrics and Risk Management with High Risk Radiation Oncology Procedures. Disclosure of Conflict of Interest

7/21/2014. Quality Metrics and Risk Management with High Risk Radiation Oncology Procedures. Disclosure of Conflict of Interest Quality Metrics and Risk Management with High Risk Radiation Oncology Procedures V. Sathiaseelan, PhD Chief Physicist Department of Radiation Oncology, Northwestern Memorial Hospital Associate Professor

More information

Acknowledgement. Prerequisites: Basic Concepts of IMRT. Overview. Therapy Continuing Education Course Clinical Implementation of IMRT for Lung Cancers

Acknowledgement. Prerequisites: Basic Concepts of IMRT. Overview. Therapy Continuing Education Course Clinical Implementation of IMRT for Lung Cancers Therapy Continuing Education Course Clinical Implementation of IMRT for Lung Cancers H. Helen Liu, PhD Department of Radiation Physics, U.T. MD Anderson Cancer Center, Houston, TX AAPM, Seattle, 2005 Acknowledgement

More information

Myth or Fact: The Diminishing Marginal Returns of Variable Creation in Data Mining Solutions

Myth or Fact: The Diminishing Marginal Returns of Variable Creation in Data Mining Solutions Myth or Fact: The Diminishing Marginal Returns of Variable in Data Mining Solutions Data Mining practitioners will tell you that much of the real value of their work is the ability to derive and create

More information

Physics testing of image detectors

Physics testing of image detectors Physics testing of image detectors Parameters to test Spatial resolution Contrast resolution Uniformity/geometric distortion Features and Weaknesses of Phantoms for CR/DR System Testing Dose response/signal

More information

Radiation Oncology Practice Accreditation Program Requirements

Radiation Oncology Practice Accreditation Program Requirements Radiation Oncology Practice Accreditation Program Requirements Contents Introduction... 3 Application for Accreditation... 3 Preliminary Self-Assessment (ROPA Website Toolkit)... 3 Checklist for Site Survey...

More information

INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR PROSTATE CANCER PATIENTS

INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR PROSTATE CANCER PATIENTS INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR PROSTATE CANCER PATIENTS HOW DOES RADIATION THERAPY WORK? Cancer is the unrestrained growth of abnormal cells within the body. Radiation therapy kills both

More information

Use of the VALIDATOR Dosimetry System for Quality Assurance and Quality Control of Blood Irradiators

Use of the VALIDATOR Dosimetry System for Quality Assurance and Quality Control of Blood Irradiators Technical Note: 9 Use of the VALIDATOR Dosimetry System for Quality Assurance and Quality Control of Blood Irradiators 1- Introduction The VALIDATOR, model TN-ID-60, is a compact, and stand-alone dosimetry

More information

Quality Assurance for Treatment Planning Systems

Quality Assurance for Treatment Planning Systems Quality Assurance for Treatment Planning Systems PTCOG Educational Session May 19 th 2010 Oliver Jäkel Heidelberg Ion Beam Therapy Center and German Cancer Research Center, Heidelberg Introduction Outline

More information

Performance evaluation and quality assurance of Varian enhanced dynamic wedges

Performance evaluation and quality assurance of Varian enhanced dynamic wedges JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 1, WINTER 2006 Performance evaluation and quality assurance of Varian enhanced dynamic wedges Parham Alaei and Patrick D. Higgins Department

More information

MEDICAL DOSIMETRY. COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: therapy.

MEDICAL DOSIMETRY. COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: therapy. Graduate Catalog 2012-2013 Medical Dosimetry / 339 MEDICAL DOSIMETRY COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: Collins, Kevin Scott, Associate Professor, Ph.D., Jensen, Steve, Emeritus Professor,

More information

DICOM: Definitions and Testing

DICOM: Definitions and Testing DICOM: Definitions and Testing Bruce Curran University of Michigan (AAPM Representative, DICOM WG-7 Walter R. Bosch Advanced Technology Consortium Washington University of St. Louis Acknowledgements Sam

More information

Worldwide Quality Assurance networks for radiotherapy dosimetry

Worldwide Quality Assurance networks for radiotherapy dosimetry Worldwide Quality Assurance networks for radiotherapy dosimetry Joanna Izewska Dosimetry and Medical Radiation Physics Section [email protected] Audit in radiotherapy dosimetry Objectives to enhance confidence

More information

Proton Therapy for Prostate Cancer

Proton Therapy for Prostate Cancer Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Director, Proton Therapy Center Associate Professor Department of Radiation Oncology M.D. Anderson Cancer Center Randomized studies showing benefit

More information

QA GLP audits. Alain Piton. Antipolis,, France. [email protected]

QA GLP audits. Alain Piton. Antipolis,, France. alain.piton@galderma.com Risk based assessment applied to QA GLP audits Alain Piton Galderma R&D, Sophia-Antipolis Antipolis,, France [email protected] RISK BASED ASSESSMENT FOR GLP AUDITS INTRODUCTION Since the origin

More information

Accreditation a tool to help reduce medical errors. Professor Arthur T Porter PC MD FACR FRCPC FACRO

Accreditation a tool to help reduce medical errors. Professor Arthur T Porter PC MD FACR FRCPC FACRO Accreditation a tool to help reduce medical errors Professor Arthur T Porter PC MD FACR FRCPC FACRO Errors in Radiotherapy Radiation therapy is a highly regulated medical practice with historically low

More information

Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT Rapid Arc Tomotherapy HD

Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT Rapid Arc Tomotherapy HD Good Morning Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT Rapid Arc Tomotherapy HD Barbara Agrimson, BS RT(T)(R), CMD Steve Rhodes, BS RT(T), CMD Disclaimer This presentation

More information

Quality Assurance in Radiotherapy

Quality Assurance in Radiotherapy Quality Assurance in Radiotherapy Patrizia Ciammella Arcispedale Santa Maria Nuova Reggio Emilia Timeline of major changes of RT in HLe RT process Riunione Nazionale FIL Timeline of major changes of RT

More information

Analyzing and interpreting data Evaluation resources from Wilder Research

Analyzing and interpreting data Evaluation resources from Wilder Research Wilder Research Analyzing and interpreting data Evaluation resources from Wilder Research Once data are collected, the next step is to analyze the data. A plan for analyzing your data should be developed

More information

Dose Measurement in Mammography; What are we measuring? David E. Hintenlang, Ph.D. DABR University of Florida

Dose Measurement in Mammography; What are we measuring? David E. Hintenlang, Ph.D. DABR University of Florida Dose Measurement in Mammography; What are we measuring? David E. Hintenlang, Ph.D. DABR University of Florida Average Glandular Dose Required measurement performed by medical physicist as part of Mammography

More information

The Practice Standards for Medical Imaging and Radiation Therapy. Quality Management Practice Standards

The Practice Standards for Medical Imaging and Radiation Therapy. Quality Management Practice Standards The Practice Standards for Medical Imaging and Radiation Therapy Quality Management Practice Standards 2015 American Society of Radiologic Technologists. All rights reserved. Reprinting all or part of

More information

SUBCHAPTER 22 QUALITY ASSURANCE PROGRAMS FOR MEDICAL DIAGNOSTIC X-RAY INSTALLATIONS

SUBCHAPTER 22 QUALITY ASSURANCE PROGRAMS FOR MEDICAL DIAGNOSTIC X-RAY INSTALLATIONS Note: This is a courtesy copy and is not the official version of this rule. The official, legally effective version of this rule is available through www.lexisnexic.com/bookstore (Phone: (800) 223-1940).

More information

MLC Characteristics. Treatment Delivery Systems 2 Field Shaping; Design Characteristics and Dosimetry Issues. Presentation Outline

MLC Characteristics. Treatment Delivery Systems 2 Field Shaping; Design Characteristics and Dosimetry Issues. Presentation Outline Treatment Delivery Systems 2 Field Shaping; Design Characteristics and Dosimetry Issues Timothy D. Solberg David Geffen School of Medicine at UCLA TU-A-517A-1 Presentation Outline MLC Characteristics TG-50

More information

Lean Six Sigma Black Belt Body of Knowledge

Lean Six Sigma Black Belt Body of Knowledge General Lean Six Sigma Defined UN Describe Nature and purpose of Lean Six Sigma Integration of Lean and Six Sigma UN Compare and contrast focus and approaches (Process Velocity and Quality) Y=f(X) Input

More information

Quantitative Imaging In Clinical Trials Using PET/CT: Update

Quantitative Imaging In Clinical Trials Using PET/CT: Update Quantitative Imaging In Clinical Trials Using PET/CT: Update Paul Kinahan, Robert Doot Imaging Research Laboratory Department of Radiology University of Washington, Seattle, WA Supported by RSNA Quantitative

More information

Guidance for Industry: Quality Risk Management

Guidance for Industry: Quality Risk Management Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating

More information

INTRODUCTION. A. Purpose

INTRODUCTION. A. Purpose New York State Department of Health Bureau of Environmental Radiation Protection Guide for Radiation Safety/Quality Assurance Programs Computed Radiography INTRODUCTION A. Purpose This guide describes

More information

Department of Radiation Oncology

Department of Radiation Oncology Department of Radiation Oncology Welcome to Radiation Oncology at Emory Clinic Every member of Emory Clinic Department of Radiation Oncology strives to provide the highest quality of care for you as our

More information

Quality Reports With. PlanIQ. *Export only. 510(k) pending. Patent pending. Your Most Valuable QA and Dosimetry Tools

Quality Reports With. PlanIQ. *Export only. 510(k) pending. Patent pending. Your Most Valuable QA and Dosimetry Tools Quality Reports With PlanIQ * *Export only. 510(k) pending. Patent pending. Your Most Valuable QA and Dosimetry Tools Objective Plan Assessment? How good are my treatment plans? Quality assurance of radiation

More information

Online Supplement to Clinical Peer Review Programs Impact on Quality and Safety in U.S. Hospitals, by Marc T. Edwards, MD

Online Supplement to Clinical Peer Review Programs Impact on Quality and Safety in U.S. Hospitals, by Marc T. Edwards, MD Online Supplement to Clinical Peer Review Programs Impact on Quality and Safety in U.S. Hospitals, by Marc T. Edwards, MD Journal of Healthcare Management 58(5), September/October 2013 Tabulated Survey

More information

Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1

Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1 Risk Assessment for Medical Devices Linda Braddon, Ph.D. Bring your medical device to market faster 1 My Perspective Work with start up medical device companies Goal: Making great ideas into profitable

More information

QA of intensity-modulated beams using dynamic MLC log files

QA of intensity-modulated beams using dynamic MLC log files 36 Original Article QA of intensity-modulated beams using dynamic MLC log files M. Dinesh Kumar, N. Thirumavalavan, D. Venugopal Krishna, M. Babaiah Department of Radiation Oncology, Yashoda Cancer Institute,

More information

Northumberland Knowledge

Northumberland Knowledge Northumberland Knowledge Know Guide How to Analyse Data - November 2012 - This page has been left blank 2 About this guide The Know Guides are a suite of documents that provide useful information about

More information

Scripps Proton Therapy Center: Configuration and Implementation

Scripps Proton Therapy Center: Configuration and Implementation Scripps Proton Therapy Center: Configuration and Implementation Anthony Mascia Proton Symposium 2013 Annual AAPM Meeting Indianapolis, Indiana USA Facility Configuration Scripps Proton Therapy Center ***All

More information

Post Treatment Log File Based QA Varian. Krishni Wijesooriya, PhD University of Virginia. D e p a r t m e n t of R a d i a t i o n O n c o l o g y

Post Treatment Log File Based QA Varian. Krishni Wijesooriya, PhD University of Virginia. D e p a r t m e n t of R a d i a t i o n O n c o l o g y Post Treatment Log File Based QA Varian Krishni Wijesooriya, PhD University of Virginia Learning Objectives What information could be accessed via log files Scenarios where Log files could be used. How

More information

IGRT. IGRT can increase the accuracy by locating the target volume before and during the treatment.

IGRT. IGRT can increase the accuracy by locating the target volume before and during the treatment. DERYA ÇÖNE RADIOTHERAPY THERAPIST ACIBADEM KOZYATAGI HOSPITAL RADIATION ONCOLOGY DEPARTMENT IGRT IGRT (image-guided radiation therapy) is a technique that reduces geometric uncertainties by considering

More information

HDR Q.A.: Physicist responsibilities. Zoubir Ouhib MS Lynn Cancer Institute Boca Raton Regional Hospital Boca Raton, FL 4/7/11

HDR Q.A.: Physicist responsibilities. Zoubir Ouhib MS Lynn Cancer Institute Boca Raton Regional Hospital Boca Raton, FL 4/7/11 HDR Q.A.: Physicist responsibilities Zoubir Ouhib MS Lynn Cancer Institute Boca Raton Regional Hospital Boca Raton, FL 4/7/11 Patient advocacy week? TOP 10 TECHNOLOGY HAZARDS FOR 2011 1. Radiation Overdose

More information

SEAAPM Symposium The Practice of Quality Assurance in an Era of Change

SEAAPM Symposium The Practice of Quality Assurance in an Era of Change SEAAPM Symposium The Practice of Quality Assurance in an Era of Change Directors: Dan Bourland and Ingrid Marshall Vendors, breaks, and food next door Thank you to SEAAPM EXCOM, Commercial Partners, Faculty,

More information

QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET

QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET Centers for Quantitative Imaging Excellence (CQIE) LEARNING MODULE QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET American College of Radiology Clinical Research Center v.1 Centers for Quantitative

More information

QUALITY RISK MANAGEMENT (QRM): A REVIEW

QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate

More information

Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services

Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services POSITION SUMMARY: The Medical Physicist is responsible for assuring the high quality radiation therapy through

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information

Chapter 12 QUALITY ASSURANCE OF EXTERNAL BEAM RADIOTHERAPY

Chapter 12 QUALITY ASSURANCE OF EXTERNAL BEAM RADIOTHERAPY Chapter 12 QUALITY ASSURANCE OF EXTERNAL BEAM RADIOTHERAPY D.I. THWAITES Department of Oncology Physics, Edinburgh Cancer Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom

More information

Intensity-Modulated Radiation Therapy (IMRT)

Intensity-Modulated Radiation Therapy (IMRT) Scan for mobile link. Intensity-Modulated Radiation Therapy (IMRT) Intensity-modulated radiotherapy (IMRT) uses linear accelerators to safely and painlessly deliver precise radiation doses to a tumor while

More information

HITACHI Proton Beam Therapy System

HITACHI Proton Beam Therapy System HITACHI Proton Beam Therapy System Masumi Umezawa, M.S. Hitachi, Ltd., Hitachi Research Laboratory HITACHI Proton Beam Therapy System Contents 1. Overview of HITACHI 2. HITACHI Proton Beam Therapy and

More information

Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014.

Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014. Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience Richard Pötter MD BrachyNext, Miami, 2014 Disclosures Richard Pötter, MD, does not have any financial relationships or

More information

Übersicht von IMRT Konzepten bei CMS. Norbert Steinhöfel DGMP AK IMRT 19.-20.2.2002

Übersicht von IMRT Konzepten bei CMS. Norbert Steinhöfel DGMP AK IMRT 19.-20.2.2002 Übersicht von IMRT Konzepten bei CMS Norbert Steinhöfel DGMP AK IMRT 19.-20.2.2002 1 CMS: Radiation Oncology Software An Integrated Department From Start to Finish CMS provides integration from CT simulation

More information

Virginia Transformer Corp. 220 Glade View Drive Roanoke, Virginia 24012 USA C0098193. Audit Type Surveillance Audit. Auditor Jennifer Edwards

Virginia Transformer Corp. 220 Glade View Drive Roanoke, Virginia 24012 USA C0098193. Audit Type Surveillance Audit. Auditor Jennifer Edwards Virginia Transformer Corp. 220 Glade View Drive Roanoke, Virginia 24012 USA C0098193 Audit Type Surveillance Audit Auditor Jennifer Edwards Standard (Exp Date: 16-JUL-2015) Recommendation : Surveillance:

More information

RADIATION ONCOLOGY PRACTICE STANDARDS A TRIPARTITE INITIATIVE

RADIATION ONCOLOGY PRACTICE STANDARDS A TRIPARTITE INITIATIVE 2011 RADIATION ONCOLOGY PRACTICE STANDARDS A TRIPARTITE INITIATIVE The Tripartite Committee is a peak group in Radiation Oncology, representing the three key professions involved in radiotherapy: The Faculty

More information

Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate

Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate

More information

REGULATION: QUALITY ASSURANCE PROGRAMS FOR MEDICAL DIAGNOSTIC X-RAY INSTALLATIONS N.J.A.C. 7:28-22

REGULATION: QUALITY ASSURANCE PROGRAMS FOR MEDICAL DIAGNOSTIC X-RAY INSTALLATIONS N.J.A.C. 7:28-22 REGULATION: QUALITY ASSURANCE PROGRAMS FOR MEDICAL DIAGNOSTIC X-RAY INSTALLATIONS N.J.A.C. 7:28-22 New Jersey Department of Environmental Protection Bureau of Radiological Health PO Box 415 Trenton NJ

More information

SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT

SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT Competition in health care sector are forcing healthcare organizations to look for new ways and means for improving their processes. This for improving

More information

CAPA - the importance of data analysis

CAPA - the importance of data analysis CAPA - the importance of data analysis Presented by: Sue Jacobs QMS Consulting, Inc. 1 847 359 4456 [email protected] QMS Consulting, Inc. 2007 1 Topics Regulatory Requirements Design Controls and

More information

Getting to Know Avreo

Getting to Know Avreo Getting to Know Avreo Avreo develops complete Radiology Workflow Solutions (RWS) that manage every aspect of your workflow from order entry to report distribution within a single application/single database

More information

Clinical Education A comprehensive and specific training program. carry out effective treatments from day one

Clinical Education A comprehensive and specific training program. carry out effective treatments from day one Proton Therapy Clinical Education A comprehensive and specific training program carry out effective treatments from day one Forewarned is forearmed Although over 100,000 patients have been treated in proton

More information

Analysis of Causes for Reject X-Ray Films as a Quality Assurance Element in Diagnostic Radiology in Jos University Teaching Hospital(JUTH)

Analysis of Causes for Reject X-Ray Films as a Quality Assurance Element in Diagnostic Radiology in Jos University Teaching Hospital(JUTH) Analysis of Causes for Reject X-Ray Films as a Quality Assurance Element in Diagnostic Radiology in Jos University Teaching Hospital(JUTH) By S.O ANIKOH Dept. of Physics, University of Jos, Jos. HABILA

More information

4D Scanning. Image Guided Radiation Therapy. Outline. A Simplified View of the RT Process. Outline. Steve B. Jiang, Ph.D.

4D Scanning. Image Guided Radiation Therapy. Outline. A Simplified View of the RT Process. Outline. Steve B. Jiang, Ph.D. 4D Scanning Steve B. Jiang, Ph.D. Department of Radiation Oncology [email protected] http://gray.mgh.harvard.edu/ Outline Problems with free breathing 3D scanning What is 4D CT? How does it work?

More information

Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D.

Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D. Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D. Melbourne Australia March 28, 2012 Synarc Experience and Expertise Largest imaging service provider dedicated to clinical

More information

First Three Years After Project Proton Therapy Facility:

First Three Years After Project Proton Therapy Facility: 39. Project Related Utilization and Financial Information. Proton Therapy Facility: Unit of Service Delivery Projected Utilization FY2017 FY2018 FY2019 Estimated Patients 448 670 808 Average Revenue Per

More information

What Is Patient Safety?

What Is Patient Safety? Patient Safety Research Introductory Course Session 1 What Is Patient Safety? David W. Bates, MD, MSc External Program Lead for Research, WHO Professor of Medicine, Harvard Medical School Professor of

More information

Innovative RT SBRT. The variables with REQ in superscript are required.

Innovative RT SBRT. The variables with REQ in superscript are required. The variables with REQ in superscript are required. The variables with a are single-select variables; only one answer can be selected. The variables with a are multi-select variables; multiple answers

More information

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. SAMPLE CLINICAL RESEARCH APPLICATION ABSTRACT: TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. Hypothesis:

More information

Patient Dose Tracking for Imaging Studies. David E. Hintenlang, Ph.D., DABR University of Florida

Patient Dose Tracking for Imaging Studies. David E. Hintenlang, Ph.D., DABR University of Florida Patient Dose Tracking for Imaging Studies David E. Hintenlang, Ph.D., DABR University of Florida Conflict of Interest Statement No affiliation or financial interests in any of the commercial products or

More information

PET/CT QC/QA. Quality Control in PET. Magnus Dahlbom, Ph.D. Verify the operational integrity of the system. PET Detectors

PET/CT QC/QA. Quality Control in PET. Magnus Dahlbom, Ph.D. Verify the operational integrity of the system. PET Detectors Quality Control in PET PET/CT QC/QA Magnus Dahlbom, Ph.D. Division of Nuclear Medicine Ahmanson Biochemical Imaging Clinic David Geffen School of Medicine at UCLA Los Angeles Verify the operational integrity

More information

WHERE IN THE WORLD JILL LIPOTI?

WHERE IN THE WORLD JILL LIPOTI? WHERE IN THE WORLD IS JILL LIPOTI? HELLO FROM NEW JERSEY CRCPD - National Symposium on Fusion Imaging and Multimodalities February 18-20, 2004 Kansas City, Missouri New Jersey s Requirements As They Pertain

More information

Content Sheet 7-1: Overview of Quality Control for Quantitative Tests

Content Sheet 7-1: Overview of Quality Control for Quantitative Tests Content Sheet 7-1: Overview of Quality Control for Quantitative Tests Role in quality management system Quality Control (QC) is a component of process control, and is a major element of the quality management

More information

Basic Results Database

Basic Results Database Basic Results Database Deborah A. Zarin, M.D. ClinicalTrials.gov December 2008 1 ClinicalTrials.gov Overview and PL 110-85 Requirements Module 1 2 Levels of Transparency Prospective Clinical Trials Registry

More information

Safety Risk Management in RT: A Software Manufacturer Perspective

Safety Risk Management in RT: A Software Manufacturer Perspective Safety Risk Management in RT: A Software Manufacturer Perspective Jim Schewe, Ph.D. Philips Radiation Oncology Systems AAPM Spring Clinical Meeting March 16, 2014 1 Learning Objectives For the session

More information